Somatic Targeted Gene Analysis (Two Genes)

The Somatic Targeted Gene Analysis (Any Two Genes) includes key genes like BRCA1 and BRCA2, which play critical roles in DNA repair and tumor suppression. Pathogenic variants in these genes can drive cancer growth and influence patient response to targeted therapies, including PARP inhibitors. This test provides essential information for healthcare providers to tailor treatment options, assess prognosis, and optimize therapeutic strategies for patients with cancers driven by somatic mutations in these genes.